bioRxivCancer BiologyPreprint
The ESCRT protein CHMP5 promotes T cell leukemia by controlling BRD4-p300-dependent transcription
K. S. Umphred-Wilson, S. Ratnayake, Q. Tang, R. Wang, B. N. Devaiah, L. Zhou, Q. Chen, D. Meerzaman, D. S. Singer, S. Adoro
Abstract
Oncogene activity rewires cellular transcription, creating new transcription networks to which cancer cells become addicted, by mechanisms that are still poorly understood. Using human and mouse models of T cell acute lymphoblastic leukemia (T-ALL), we identify an essential nuclear role for CHMP5, a cytoplasmic endosomal sorting complex required for transport (ESCRT) protein, in establishing and maintaining the T-ALL transcriptional program. Nuclear CHMP5 promoted the T-ALL gene program by augmenting recruitment of the co-activator BRD4 by the histone acetyl transferase p300 selectively at enhancers and super-enhancers, an interaction that potentiated H3K27 acetylation at these regulatory enhancers. Consequently, loss of CHMP5 diminished BRD4 occupancy at enhancers and super-enhancers and impaired RNA polymerase II pause release, which resulted in downregulation of key T-ALL genes, notably MYC. Reinforcing its importance in T-ALL pathogenesis, CHMP5 deficiency mitigated chemoresistance in human T-ALL cells and abrogated T-ALL induction by oncogenic NOTCH1 in vivo. Thus, the ESCRT protein CHMP5 is an essential positive regulator of the transcriptional machinery promoting T-ALL disease. Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/577409v1_ufig1.gif" ALT="Figure 1"> View larger version (59K): org.highwire.dtl.DTLVardef@191e10dorg.highwire.dtl.DTLVardef@4e5093org.highwire.dtl.DTLVardef@18c0a08org.highwire.dtl.DTLVardef@e6a887_HPS_FORMAT_FIGEXP M_FIG C_FIG HighlightsO_LIIdentification of a nuclear role for the cytosolic ESCRT protein CHMP5 in transcription C_LIO_LICHMP5 mediates BRD4-dependent Pol II pause release and transcription of T-ALL genes C_LIO_LIP300-BRD4 induced enhancer and super-enhancer H3K27 acetylation requires CHMP5 C_LIO_LICHMP5 depletion mitigates chemoresistance and abrogates T-ALL initiation in vivo C_LI
- organism: human
- organism: mouse
- assay: bulk RNA-seq
- assay: ChIP-seq
- assay: proteomics
- research focus: cell type annotation
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- research focus: development & morphogenesis
- approach: genetic perturbation / CRISPR
- approach: statistical model
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- HDAC1 regulates the chromatin landscape to establish transcriptional dependencies in chronic lymphocytic leukemia
T.-h. Lai, H. G. Ozer, … D. Sampath·bioRxiv·Aug 3, 2020
- Critical roles of Ikaros and HDAC1 in regulation of heterochromatin and tumor suppression in T-cell acute lymphoblastic leukemia
Yali Ding, Bing He, … Sinisa Dovat·LeukemiaPeer-reviewed·Jun 24, 2025
- STAT5 Gain-of-Function Variants Promote Precursor T-Cell Receptor Activation to Drive T-Cell Acute Lymphoblastic Leukemia
T. Suske, H. Sorger, … R. Moriggl·bioRxiv·Dec 21, 2022
- USP7 cooperates with NOTCH1 to drive the oncogenic transcriptionalprogram in T cell leukemia
P. Ntziachristos, K. Arcipowski, … J. D Crispino·bioRxiv·Jan 16, 2018
- Cdc73 protects Notch-induced T-cell leukemia cells from DNA damage and mitochondrial stress
A. Melnick, S. Liang, … M. Y. Chiang·bioRxiv·Jan 22, 2023
- Transgenic αβ TCR tonic signaling is leukemogenic while strong stimulation is leukemia-suppressive
T. A. Catarino, I. Pacheco-Leyva, … N. R. dos Santos·bioRxiv·Jan 17, 2024